3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Neoplasms
4
Recurrence
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Breast Diseases
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Triple Negative Breast Neoplasms
1
Spinal Cord Neoplasms
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Ovarian Neoplasms
1
Neurofibromatosis 1
1
Neoplasms, Squamous Cell
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Liposarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
HR+/HER2- Breast Cancer
1
Glioma
1
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
1
Central Nervous System Neoplasms
1
Central Nervous System Diseases
1
Brain Diseases
1
Interventions
Cyclophosphamide
6
pembrolizumab
5
fludarabine phosphate
5
Vinblastine
5
Nivolumab
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
fludarabine
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
pegfilgrastim
3
Etoposide
3
Cyclosporine
3
Busulfan
3
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Azacitidine
2
treosulfan
1
tocilizumab
1
thymoglobulin
1
tafasitamab
1
selinexor
1
polatuzumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
abemaciclib
×
30 days
×
Clear all
No trials found.